Preventing synaptic deficits in Alzheimer’s disease by inhibiting tumor necrosis factor alpha signaling
The characterization of preclinical stages of Alzheimer’s disease (AD) would provide a therapeutic window for prevention. One of the challenges of developing preventive therapy for AD is to identify early biomarkers for intervention studies. We have recently shown that in the TgCRND8 transgenic AD m...
Main Authors: | Chelsea Cavanagh, Tak Pan Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | IBRO Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451830117300468 |
Similar Items
-
Determination of Adiponectin, Tumor Necrosis Factor-Alpha, and Adhesion Molecules in Alzheimer's Disease
by: Sumru Savaş, et al.
Published: (2019-05-01) -
Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
by: Culpan, D, et al.
Published: (2003) -
Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha.
by: Fekade, D, et al.
Published: (1996) -
Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
by: Ulfgren, A, et al.
Published: (2000) -
Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
by: Wei-Cheng Tseng, et al.
Published: (2023-01-01)